Category > Discover Digital Health Startups in Decentralised Clinical Trials

Discover Digital Health Startups in Decentralised Clinical Trials

As of July 2026, the Decentralised Clinical Trials category has a total of 90 Digital Health firms. The total venture volume has expanded at a CAGR of 3.2% over the past 5 years. The ventures have an average venture maturity score of 229.2.

From a funding perspective, these Digital Health companies have successfully raised $2.64B in venture capital investments, channeled through 202 distinct funding rounds. In the past 12 months, total venture capital funding closed at $58.20M across 6 deals.

Last Updated: April 11, 2026

Ventures

Venture	Primary Category	Country	Therapeutic Focus	Valuation	Stage	Current Funding
Suvoda	Decentralised Clinical Trials	United States	xyrsttzsas	$ 123.46 B	Private Equity	$ 40.00 M
Medable	Decentralised Clinical Trials	United States	xyrsttzsas	$ 123.46 B	Series D	$ 304.00 M
Lightship	Decentralised Clinical Trials	United States	xyrsttzsas	$ 123.46 B	Series D	$ 135.55 M
Teckro	Decentralised Clinical Trials	Ireland	xyrsttzsas	$ 123.46 B	Series C	$ 25.00 M
Curebase	Decentralised Clinical Trials	United States	xyrsttzsas	$ 123.46 B	Series B	$ 40.00 M
ObvioHealth	Decentralised Clinical Trials	United States	xyrsttzsas	$ 123.46 B	Series D1	$ 3.40 M
DIP (深度智耀)	Decentralised Clinical Trials	Singapore	xyrsttzsas	$ 123.46 B	Series D	$ 50.00 M
Caidya	Decentralised Clinical Trials	China	xyrsttzsas	$ 123.46 B	Series B	$ 50.00 M
Florence Healthcare	Decentralised Clinical Trials	United States	xyrsttzsas	$ 123.46 B	Series C1	$ 27.00 M
Castor	Decentralised Clinical Trials	Netherlands	xyrsttzsas	$ 123.46 B	Series B	$ 45.00 M

Showing 1 to 10 of 90 entries